Tokyo Tape
Sign in
← Sumitomo Chemical

Quarterly report · Q1

4005.TEDINET S100OVSY
Period2022-04-01 → 2022-06-30
Filed2022-08-05
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 45
MetricValuePeriodScopeSource row
Revenue¥774.1bn2022-04-01 → 2022-06-30Cons.Revenue IFRS
Revenue¥2.77T2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥639.0bn2021-04-01 → 2021-06-30Cons.Revenue IFRS
Operating income¥66.3bn2022-04-01 → 2022-06-30Cons.Operating profit loss IFRS
Operating income¥58.3bn2021-04-01 → 2021-06-30Cons.Operating profit loss IFRS
Profit before tax¥113.7bn2022-04-01 → 2022-06-30Cons.Profit loss before tax IFRS
Profit before tax¥251.1bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥56.7bn2021-04-01 → 2021-06-30Cons.Profit loss before tax IFRS
Net income (owners)¥70.0bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥162.1bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥35.7bn2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥85.1bn2022-04-01 → 2022-06-30Cons.Profit loss IFRS
Net income¥186.4bn2021-04-01 → 2022-03-31Cons.Profit loss IFRS (5-year summary)
Net income¥38.9bn2021-04-01 → 2021-06-30Cons.Profit loss IFRS
Total assets¥4.67Tat 2022-06-30Cons.Assets IFRS
Total assets¥4.31Tat 2022-03-31Cons.Assets IFRS
Total assets¥4.09Tat 2021-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥2.81Tat 2022-06-30Cons.Liabilities IFRS
Total liabilities¥2.61Tat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥1.86Tat 2022-06-30Cons.Equity IFRS
Net assets / equity¥1.70Tat 2022-03-31Cons.Equity IFRS
Net assets / equity¥1.50Tat 2021-06-30Cons.Equity IFRS
Net assets / equity¥1.48Tat 2021-03-31dCons.Equity IFRS
Equity (owners)¥1.34Tat 2022-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.22Tat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.05Tat 2021-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥498.6bnat 2022-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥365.4bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥366.5bnat 2021-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥360.9bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥42.6bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥171.7bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥4.7bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow¥46.0bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥115.4bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥41.3bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥11.5bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥81.4bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥41.5bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥42.812022-04-01 → 2022-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥99.162021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥21.812021-04-01 → 2021-06-30Cons.Basic earnings loss per share IFRS
Equity ratio28.8%at 2022-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio28.3%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio25.5%at 2021-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 62
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-06-30¥31.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-06-30¥14.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-06-30¥17.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-06-30¥3.3bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥24.8bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥24.8bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥7.5bn
jpcrp040300-q1r_E00752-000Energy And Functional Materialsreportable segmentrevenue2022-04-01 → 2022-06-30¥91.3bn
jpcrp040300-q1r_E00752-000Energy And Functional Materialsreportable segmentrevenue external2022-04-01 → 2022-06-30¥86.4bn
jpcrp040300-q1r_E00752-000Energy And Functional Materialsreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥4.8bn
jpcrp040300-q1r_E00752-000Energy And Functional Materialsreportable segmentsegment profit2022-04-01 → 2022-06-30¥6.6bn
jpcrp040300-q1r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue2022-04-01 → 2022-06-30¥240.0bn
jpcrp040300-q1r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue external2022-04-01 → 2022-06-30¥238.6bn
jpcrp040300-q1r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥1.5bn
jpcrp040300-q1r_E00752-000Essential Chemicals And Plasticsreportable segmentsegment profit2022-04-01 → 2022-06-30¥10.0bn
jpcrp040300-q1r_E00752-000Health And Agriculture Relatedreportable segmentrevenue2022-04-01 → 2022-06-30¥153.5bn
jpcrp040300-q1r_E00752-000Health And Agriculture Relatedreportable segmentrevenue external2022-04-01 → 2022-06-30¥152.6bn
jpcrp040300-q1r_E00752-000Health And Agriculture Relatedreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥945m
jpcrp040300-q1r_E00752-000Health And Agriculture Relatedreportable segmentsegment profit2022-04-01 → 2022-06-30¥21.9bn
jpcrp040300-q1r_E00752-000Information Electronic Chemistryreportable segmentrevenue2022-04-01 → 2022-06-30¥114.8bn
jpcrp040300-q1r_E00752-000Information Electronic Chemistryreportable segmentrevenue external2022-04-01 → 2022-06-30¥114.7bn
jpcrp040300-q1r_E00752-000Information Electronic Chemistryreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥116m
jpcrp040300-q1r_E00752-000Information Electronic Chemistryreportable segmentsegment profit2022-04-01 → 2022-06-30¥15.8bn
jpcrp040300-q1r_E00752-000Medical Productsreportable segmentrevenue2022-04-01 → 2022-06-30¥167.7bn
jpcrp040300-q1r_E00752-000Medical Productsreportable segmentrevenue external2022-04-01 → 2022-06-30¥167.7bn
jpcrp040300-q1r_E00752-000Medical Productsreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥6m
jpcrp040300-q1r_E00752-000Medical Productsreportable segmentsegment profit2022-04-01 → 2022-06-30¥14.1bn
—segment totalrevenue2022-04-01 → 2022-06-30¥767.3bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥759.9bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥7.4bn
—segment totalsegment profit2022-04-01 → 2022-06-30¥68.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-06-30¥27.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-06-30¥13.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-06-30¥14.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-06-30¥2.7bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30−¥21.0bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-06-30−¥21.0bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30−¥5.0bn
jpcrp040300-q1r_E00752-000Energy And Functional Materialsreportable segmentrevenue2021-04-01 → 2021-06-30¥77.4bn
jpcrp040300-q1r_E00752-000Energy And Functional Materialsreportable segmentrevenue external2021-04-01 → 2021-06-30¥74.4bn
jpcrp040300-q1r_E00752-000Energy And Functional Materialsreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥3.0bn
jpcrp040300-q1r_E00752-000Energy And Functional Materialsreportable segmentsegment profit2021-04-01 → 2021-06-30¥6.7bn
jpcrp040300-q1r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue2021-04-01 → 2021-06-30¥200.8bn
jpcrp040300-q1r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue external2021-04-01 → 2021-06-30¥199.5bn
jpcrp040300-q1r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥1.2bn
jpcrp040300-q1r_E00752-000Essential Chemicals And Plasticsreportable segmentsegment profit2021-04-01 → 2021-06-30¥23.8bn
jpcrp040300-q1r_E00752-000Health And Agriculture Relatedreportable segmentrevenue2021-04-01 → 2021-06-30¥105.4bn
jpcrp040300-q1r_E00752-000Health And Agriculture Relatedreportable segmentrevenue external2021-04-01 → 2021-06-30¥103.1bn
jpcrp040300-q1r_E00752-000Health And Agriculture Relatedreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥2.4bn
jpcrp040300-q1r_E00752-000Health And Agriculture Relatedreportable segmentsegment profit2021-04-01 → 2021-06-30¥10.3bn
jpcrp040300-q1r_E00752-000Information Electronic Chemistryreportable segmentrevenue2021-04-01 → 2021-06-30¥109.4bn
jpcrp040300-q1r_E00752-000Information Electronic Chemistryreportable segmentrevenue external2021-04-01 → 2021-06-30¥109.3bn
jpcrp040300-q1r_E00752-000Information Electronic Chemistryreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥110m
jpcrp040300-q1r_E00752-000Information Electronic Chemistryreportable segmentsegment profit2021-04-01 → 2021-06-30¥13.5bn
jpcrp040300-q1r_E00752-000Medical Productsreportable segmentrevenue2021-04-01 → 2021-06-30¥139.2bn
jpcrp040300-q1r_E00752-000Medical Productsreportable segmentrevenue external2021-04-01 → 2021-06-30¥139.2bn
jpcrp040300-q1r_E00752-000Medical Productsreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥2m
jpcrp040300-q1r_E00752-000Medical Productsreportable segmentsegment profit2021-04-01 → 2021-06-30¥9.6bn
—segment totalrevenue2021-04-01 → 2021-06-30¥632.1bn
—segment totalrevenue external2021-04-01 → 2021-06-30¥625.4bn
—segment totalrevenue intersegment2021-04-01 → 2021-06-30¥6.7bn
—segment totalsegment profit2021-04-01 → 2021-06-30¥63.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 785
ItemContextValueUnit
Transactions with non controlling interests ss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Transactions with non controlling interests ss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember750000000JPY
Transactions with non controlling interests ss IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember1665000000JPY
Transactions with non controlling interests ss IFRSPrior1YTDDuration2415000000JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1YTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember－JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember-4986000000JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember－JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember－JPY
Transfer from other components of equity to retained earnings ss IFRSPrior1YTDDuration－JPY
Other ss IFRSPrior1YTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember－JPY
Other ss IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Other ss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember-5000000JPY
Other ss IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember－JPY
Other ss IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember－JPY
Other ss IFRSPrior1YTDDuration－JPY
Total transactions with owners IFRSPrior1YTDDuration_EffectivePortionOfCashFlowHedgesIFRSMember－JPY
Total transactions with owners IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Total transactions with owners IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember-4991000000JPY
Total transactions with owners IFRSPrior1YTDDuration_EquityAttributableToOwnersOfParentIFRSMember-13967000000JPY
Total transactions with owners IFRSPrior1YTDDuration_NonControllingInterestsIFRSMember-3682000000JPY
Total transactions with owners IFRSPrior1YTDDuration-17649000000JPY
Equity IFRSPrior1QuarterInstant_EffectivePortionOfCashFlowHedgesIFRSMember-4100000000JPY
Equity IFRSPrior1QuarterInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember-17065000000JPY
Equity IFRSPrior1QuarterInstant_OtherComponentsOfEquityIFRSMember56108000000JPY
Equity IFRSPrior1QuarterInstant_EquityAttributableToOwnersOfParentIFRSMember1045576000000JPY
Equity IFRSPrior1QuarterInstant_NonControllingInterestsIFRSMember458126000000JPY
Equity IFRSPrior1QuarterInstant1503702000000JPY
Equity IFRSPrior1YearInstant_ShareCapitalIFRSMember89699000000JPY
Equity IFRSPrior1YearInstant_CapitalSurplusIFRSMember27089000000JPY
Equity IFRSPrior1YearInstant_RetainedEarningsIFRSMember974382000000JPY
Equity IFRSPrior1YearInstant_TreasurySharesIFRSMember-8343000000JPY
Equity IFRSPrior1YearInstant_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember82682000000JPY
Equity IFRSPrior1YearInstant_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Profit loss IFRSCurrentYTDDuration_ShareCapitalIFRSMember－JPY
Profit loss IFRSCurrentYTDDuration_CapitalSurplusIFRSMember－JPY
Profit loss IFRSCurrentYTDDuration_RetainedEarningsIFRSMember69992000000JPY
Profit loss IFRSCurrentYTDDuration_TreasurySharesIFRSMember－JPY
Profit loss IFRSCurrentYTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember－JPY
Profit loss IFRSCurrentYTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember－JPY
Other comprehensive income IFRSCurrentYTDDuration_ShareCapitalIFRSMember－JPY
Other comprehensive income IFRSCurrentYTDDuration_CapitalSurplusIFRSMember－JPY
Other comprehensive income IFRSCurrentYTDDuration_RetainedEarningsIFRSMember－JPY
Other comprehensive income IFRSCurrentYTDDuration_TreasurySharesIFRSMember－JPY
Other comprehensive income IFRSCurrentYTDDuration_FinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncomeIFRSMember-6682000000JPY
Other comprehensive income IFRSCurrentYTDDuration_RemeasurementsOfDefinedBenefitPlansIFRSMember-33000000JPY
Comprehensive income IFRSCurrentYTDDuration_ShareCapitalIFRSMember－JPY
Comprehensive income IFRSCurrentYTDDuration_CapitalSurplusIFRSMember－JPY
Comprehensive income IFRSCurrentYTDDuration_RetainedEarningsIFRSMember69992000000JPY
Comprehensive income IFRSCurrentYTDDuration_TreasurySharesIFRSMember－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-06-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass